Abstract

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension

Author(s): McElhiney Linda F

Issue: Jan/Feb 2021 - Volume 25, Number 1

Page(s): 24-28

Download in electronic PDF format for $75
  • Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 1
  • Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 2
  • Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 3
  • Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 4
  • Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 5

Abstract

Pediatric patients are sensitive to bitter-tasting substances and often resist taking them orally; however, they do like sweet substances from birth through mid-adolescence. To improve compliance, compounding pharmacists need to consider the palatability of compounded medications in addition to stability, safety, and effectiveness. Metronidazole compounded oral suspension is commonly prepared with the benzoate ester because it does not have a bitter taste; however, it has been on backorder and unavailable for months. A palatable metronidazole compounded oral suspension needs to be developed using the metronidazole base in order to meet the treatment needs of pediatric patients and improve compliance during this shortage.

Related Keywords

  • metronidazole benzoate
  • children
  • taste perception
  • formulations
  • patient compliance
  • bitterness
  • amebicide
  • antibiotic
  • antiprotozoal agent
  • oral suspension bases

Related Categories

  • HRT
  • LEGAL
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2021
Pg. 24-28
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
Author(s): McElhiney Linda F
Jul/Aug 2018
Pg. 320
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 98-102
Compounding Pearls -- Wound Care: Base Selection
Author(s): Riepl Mike
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Nov/Dec 2008
Pg. 558-564
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Sep/Oct 2021
Pg. 396-400
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 46
Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 214-217
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy
Author(s): Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
May/Jun 2015
Pg. 248-251
Stability of Metronidazole Suspensions
Author(s): Donnelly Ronald F, Ying James
Jan/Feb 2023
Pg. 72-77
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Mar/Apr 2021
Pg. 169-175
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 1999
Pg. 34-35
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Author(s): Mason Dave
Sep/Oct 2021
Pg. 431-439
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2016
Pg. 257-261
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea